Kimberly-Clark, the maker of Huggies diapers and Kleenex tissues, held its full-year sales and profit forecast on Tuesday, even as it acknowledged that false social media claims in China about its diaper quality are still hurting demand. The company also trimmed its third-quarter organic sales outlook, underscoring how a trust-based category like baby care can take time to recover even after regulators step in.
What happened
The trouble began in June, when posts on Chinese social media alleged that Huggies diapers contained formamide, a chemical described in the reports as an irritant. China's market regulator later said it found no formamide and cleared the products in October. But Kimberly-Clark said consumer confidence has not fully bounced back, and the episode continues to weigh on sales.
Management said the controversy knocked 270 basis points off third-quarter organic sales. It is still expected to shave about 100 basis points off full-year organic growth, leaving the business growing slower than the markets it competes in. Organic sales, which exclude the effects of currency swings and acquisitions, are a key measure of underlying demand for consumer staples companies.
The company's decision to stick with its full-year forecast suggests management believes the damage is manageable. But the lingering impact highlights how difficult it can be to restore trust in a category where parents are making decisions about their babies' health and safety.
Why the cleanup is costly
Rebuilding demand in China is not just about convincing parents the product is safe. Retailers and online platforms, which are also sensitive to consumer sentiment, may demand more promotions and support before they give Huggies prominent shelf space or search placement. That trade spending can be expensive and can weaken what investors call “price-mix” — the boost to revenue that comes from selling higher-priced products or a better mix of items.
Kimberly-Clark's adjusted gross margin already fell to 35.5% from a year earlier, following price cuts, higher input costs, and investment in its supply chain. That leaves the company with less cushion if it needs to spend more to win back market share. In the consumer staples world, where growth is often modest, margin pressure can be a bigger concern than a temporary dip in sales.
What it means for investors
For investors, the key risk is second-order. Even if Kimberly-Clark holds its top-line outlook, a longer rebuild in China could keep margins under pressure and make it harder for the company to outgrow the broader diaper and tissue categories. The company's ability to maintain its forecast is a positive sign, but the market will be watching whether the China drag fades as expected or lingers into next year.
This is not the first time a consumer company has faced a trust crisis in a major market. In categories like baby care, an official all-clear does not instantly reset shopping habits. Parents may remain hesitant for months, and retailers may stay cautious about how much space they give the brand. That means the cost of winning back customers can extend well beyond the initial incident.
Kimberly-Clark's experience in China also offers a broader lesson for investors in consumer staples: regulatory clearance is not the same as consumer clearance. Companies in trust-based categories often need to invest heavily in marketing, promotions, and retailer relationships to rebuild demand, and those costs can show up in weaker pricing power and margins for several quarters.
The company's full-year forecast, which it maintained, suggests management sees the China issue as a manageable headwind rather than a structural problem. But the trimmed third-quarter outlook is a reminder that the recovery is not happening as quickly as hoped. Investors will likely focus on whether the 100-basis-point full-year drag narrows in the coming quarters, and whether margins can hold up if the company has to spend more to defend its share.
For now, Kimberly-Clark is betting that the worst is behind it. But in the world of diapers and tissues, trust is everything — and rebuilding it takes time.
